RecallDepth
Class II Terminated

Amlodipine Besylate Tablets, USP, 2.5 mg*, packaged in a)100-count (10 x 10) unit dose blisters per carton, NDC 51079-450-20 and b) 30-count tablets per dosage card in a carton, NDC 51079-450-63, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505; Packaged and Distributed By: UDL Laboratories, Inc., Rockford, IL 61103.

Company
Mylan Institutional, Inc. (D.B.A. Udl Laboratories)
Recall Initiated
September 17, 2013
Posted
August 31, 2016
Recall Number
D-1466-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 9,156 cartons; b) 521,310 cartons
Firm Location
Rockford, IL, United States

Reason for Recall

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Distribution

Nationwide, Puerto Rico and Guam

Lot / Code Info

Lot #: a) 3039792, Exp 04/14; 3037880, Exp 01/14; 3043938, Exp 07/14; b) 3036811, Exp 10/13; 3037514, Exp 01/14; 3039975, Exp 04/14; 3042583, Exp 07/14

More recalls by Mylan Institutional, Inc. (D.B.A. Udl Laboratories)

View all recalls by this company →

Other recent Class II Drug recalls